Morgan Stanley cut its stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 43.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 211,255 shares of the medical technology company’s stock after selling 163,063 shares during the period. Morgan Stanley owned about 0.32% of Hill-Rom Holdings worth $14,914,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in shares of Hill-Rom Holdings by 17.5% in the first quarter. Vanguard Group Inc. now owns 5,737,481 shares of the medical technology company’s stock valued at $405,066,000 after buying an additional 853,385 shares during the period. Neuberger Berman Group LLC increased its stake in shares of Hill-Rom Holdings by 15.6% in the first quarter. Neuberger Berman Group LLC now owns 1,480,242 shares of the medical technology company’s stock valued at $104,505,000 after buying an additional 199,901 shares during the period. Bank of Montreal Can increased its stake in shares of Hill-Rom Holdings by 294.3% in the first quarter. Bank of Montreal Can now owns 987,030 shares of the medical technology company’s stock valued at $69,684,000 after buying an additional 736,681 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Hill-Rom Holdings by 7.7% in the first quarter. Bank of New York Mellon Corp now owns 807,720 shares of the medical technology company’s stock valued at $57,024,000 after buying an additional 57,895 shares during the period. Finally, LSV Asset Management increased its stake in shares of Hill-Rom Holdings by 26.6% in the first quarter. LSV Asset Management now owns 723,746 shares of the medical technology company’s stock valued at $51,096,000 after buying an additional 151,946 shares during the period. Hedge funds and other institutional investors own 83.86% of the company’s stock.

Shares of Hill-Rom Holdings Inc (HRC) opened at 83.01 on Wednesday. The company has a 50 day moving average price of $80.03 and a 200-day moving average price of $70.63. The firm has a market capitalization of $5.46 billion, a PE ratio of 35.86 and a beta of 1.23. Hill-Rom Holdings Inc has a 12 month low of $50.50 and a 12 month high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings data on Friday, April 28th. The medical technology company reported $0.88 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.09. The firm had revenue of $678.90 million during the quarter, compared to analyst estimates of $654.27 million. Hill-Rom Holdings had a return on equity of 19.77% and a net margin of 5.80%. Hill-Rom Holdings’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.71 earnings per share. Equities research analysts expect that Hill-Rom Holdings Inc will post $3.86 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 30th. Investors of record on Friday, June 16th were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.87%. The ex-dividend date of this dividend was Wednesday, June 14th. Hill-Rom Holdings’s dividend payout ratio is currently 31.03%.

ILLEGAL ACTIVITY NOTICE: “Hill-Rom Holdings Inc (HRC) Shares Sold by Morgan Stanley” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/07/19/hill-rom-holdings-inc-hrc-shares-sold-by-morgan-stanley.html.

Several brokerages have weighed in on HRC. Zacks Investment Research downgraded Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Thursday, May 25th. Barclays PLC upped their price target on Hill-Rom Holdings from $75.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, May 1st. Needham & Company LLC began coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They set a “buy” rating and a $95.00 price target on the stock. Cantor Fitzgerald began coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They set a “neutral” rating and a $86.00 price target on the stock. Finally, Stifel Nicolaus upped their price target on Hill-Rom Holdings from $70.00 to $84.00 and gave the stock a “buy” rating in a report on Monday, May 1st. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Hill-Rom Holdings currently has a consensus rating of “Buy” and a consensus target price of $88.50.

In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of Hill-Rom Holdings stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total value of $150,239.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Andreas G. Frank sold 10,660 shares of Hill-Rom Holdings stock in a transaction that occurred on Tuesday, June 6th. The shares were sold at an average price of $78.62, for a total value of $838,089.20. Following the completion of the transaction, the senior vice president now owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Stock Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related stocks with our FREE daily email newsletter.